IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TRIGGIANI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.773
AS - Asia 3.664
EU - Europa 3.240
SA - Sud America 616
AF - Africa 84
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.396
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.606
SG - Singapore 1.296
CN - Cina 1.056
IT - Italia 690
PL - Polonia 496
BR - Brasile 492
DE - Germania 453
HK - Hong Kong 397
UA - Ucraina 386
VN - Vietnam 273
FI - Finlandia 245
FR - Francia 198
GB - Regno Unito 185
BD - Bangladesh 154
RU - Federazione Russa 138
TR - Turchia 137
IN - India 114
BE - Belgio 105
IE - Irlanda 100
CA - Canada 83
MX - Messico 51
ID - Indonesia 45
AR - Argentina 42
IQ - Iraq 40
CZ - Repubblica Ceca 39
ES - Italia 36
NL - Olanda 35
SE - Svezia 31
ZA - Sudafrica 31
JP - Giappone 28
EC - Ecuador 25
SA - Arabia Saudita 18
CO - Colombia 17
MA - Marocco 16
AT - Austria 15
VE - Venezuela 15
GR - Grecia 13
PK - Pakistan 13
UZ - Uzbekistan 13
LT - Lituania 12
AU - Australia 11
DZ - Algeria 11
AE - Emirati Arabi Uniti 9
AL - Albania 8
EG - Egitto 8
HU - Ungheria 8
JM - Giamaica 8
TN - Tunisia 8
BO - Bolivia 6
CL - Cile 6
EU - Europa 6
JO - Giordania 6
PY - Paraguay 6
AZ - Azerbaigian 5
CH - Svizzera 5
IL - Israele 5
KH - Cambogia 5
NP - Nepal 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
LB - Libano 4
LV - Lettonia 4
PE - Perù 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
CY - Cipro 3
HN - Honduras 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
OM - Oman 3
PA - Panama 3
BG - Bulgaria 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
IS - Islanda 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CR - Costa Rica 1
ET - Etiopia 1
Totale 15.381
Salva come PNG Salva come JPEG
Città #
Ashburn 898
Singapore 702
Fairfield 701
Warsaw 487
Woodbridge 442
San Jose 400
Hong Kong 392
Houston 349
Seattle 313
Chandler 312
Cambridge 288
New York 287
Jacksonville 283
Wilmington 243
Beijing 233
The Dalles 233
Los Angeles 206
Helsinki 192
Ann Arbor 189
Princeton 165
Dallas 156
Dearborn 146
Brescia 121
Munich 121
Istanbul 104
Lauterbourg 103
Dublin 97
Ho Chi Minh City 90
Leuven 90
Shanghai 79
Nanjing 74
Milan 69
Council Bluffs 68
San Francisco 56
Santa Clara 55
Des Moines 51
Buffalo 48
Dong Ket 46
Moscow 45
São Paulo 45
Chicago 42
Redondo Beach 42
Hanoi 41
Orem 39
Boardman 38
San Diego 38
Frankfurt am Main 36
Jakarta 33
London 33
Washington 33
Denver 32
Chennai 31
Montreal 31
Brno 29
Nanchang 29
Turku 29
Shenyang 28
Brooklyn 27
Changsha 25
Jinan 23
Tokyo 22
Boston 21
Nuremberg 21
Poplar 21
Hebei 20
Phoenix 20
Mexico City 19
Verona 19
Zhengzhou 19
Atlanta 18
Johannesburg 18
Toronto 18
Baghdad 17
Kunming 16
Rome 16
Tianjin 16
Brussels 15
Rio de Janeiro 15
Romola 15
Bari 14
Naples 14
Stockholm 14
Haiphong 13
Jiaxing 13
Quito 13
Barcelona 12
Da Nang 12
Hangzhou 12
Lancaster 12
Ningbo 12
Tashkent 12
Athens 11
Belo Horizonte 11
New Delhi 11
Ribeirão Preto 11
Amsterdam 10
Ankara 10
Brasília 10
Charlotte 10
Düsseldorf 10
Totale 10.231
Salva come PNG Salva come JPEG
Nome #
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 269
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 263
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 251
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 251
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 249
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 227
Pros-IT CNR: an Italian prostate cancer monitoring project 224
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 222
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 220
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 215
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 212
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 210
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 210
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 192
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 191
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 188
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 185
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 180
GUROPA survey: genito-urinary radiation oncology prescription attitudes 180
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 177
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 176
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 176
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 175
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 173
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 171
Role of external beam radiotherapy in the treatment of relapsing meningioma 171
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 170
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 169
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 166
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 165
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 162
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 162
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 160
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 158
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 157
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 157
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 156
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 155
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 153
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 150
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 147
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 147
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 146
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy 143
Cetuximab and Radiation Therapy in Head and Neck Cancer 143
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 142
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 140
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 140
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 140
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 140
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 139
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 138
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 135
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 133
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 133
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 133
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 130
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 127
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 127
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 125
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 125
Applying radiation protection and safety in radiotherapy 122
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 121
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 116
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 111
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 109
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 109
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 109
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 108
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 106
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 105
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 103
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 103
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 102
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 102
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 102
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 101
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 101
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 99
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 99
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 97
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 94
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 89
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 88
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 84
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 84
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 83
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 82
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP) 81
Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation 81
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group 81
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 81
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: A view of the nation's young oncologists 81
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 80
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature 79
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor 78
Totale 14.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 0 0 135
2021/2022751 65 100 26 28 12 49 31 67 39 83 38 213
2022/2023878 97 35 34 52 90 186 13 106 157 5 64 39
2023/20241.371 69 28 165 75 71 302 50 89 206 49 65 202
2024/20252.275 33 35 29 340 180 208 190 117 249 160 449 285
2025/20265.491 516 610 388 714 619 361 800 206 382 472 253 170
Totale 15.640